OTC:VRBCF Virbac (VRBCF) Stock Price, News & Analysis $324.00 0.00 (0.00%) As of 04/2/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Virbac Stock (OTC:VRBCF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Virbac alerts:Sign Up Key Stats Today's Range$324.00▼$324.0050-Day Range$324.00▼$341.3452-Week Range$324.00▼$383.52VolumeN/AAverage Volume69 shsMarket CapitalizationN/AP/E Ratio48.99Dividend Yield0.59%Price TargetN/AConsensus RatingN/A Company OverviewVirbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.Read More… Remove Ads Receive VRBCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Virbac and its competitors with MarketBeat's FREE daily newsletter. Email Address VRBCF Stock News HeadlinesVirbac (OTC:VRBCF) Stock Price Down 0.2% - Here's What HappenedApril 1 at 1:43 AM | americanbankingnews.comJefferies Sticks to Its Hold Rating for Virbac SA (0NM7)March 24, 2025 | markets.businessinsider.comTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.April 3, 2025 | American Alternative (Ad)Full Year 2024 Virbac SA Earnings Presentation TranscriptMarch 19, 2025 | gurufocus.comVirbac SA (VRBCF) Q4 2024 Earnings Call TranscriptMarch 18, 2025 | seekingalpha.comKepler Capital Remains a Hold on Virbac SA (0NM7)March 16, 2025 | markets.businessinsider.comVirbac: Public Release of the Year-End Consolidated Accounts at 31 December 2024March 13, 2025 | globenewswire.comVirbac: 2024 Annual resultsMarch 13, 2025 | globenewswire.comSee More Headlines VRBCF Stock Analysis - Frequently Asked Questions How have VRBCF shares performed this year? Virbac's stock was trading at $339.23 on January 1st, 2025. Since then, VRBCF stock has decreased by 4.5% and is now trading at $324.00. View the best growth stocks for 2025 here. How do I buy shares of Virbac? Shares of VRBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Drug Manufacturers - General Sub-IndustryN/A Current SymbolOTC:VRBCF CIKN/A Webwww.virbac.fr Phone33.4.92.08.71.00FaxN/AEmployees5,459Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio48.99 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (OTC:VRBCF) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virbac SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Virbac With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
